(redirected from Aneurysmal Subarachnoid Hemorrhage)
ASAHAcylsphingosine Amidohydrolase
ASAHAneurysmal Subarachnoid Hemorrhage
ASAHAssociation au Service de l'Action Humanitaire
ASAHAssociation of Schools and Agencies for the Handicapped (Hamilton Square, NJ)
ASAHAuckland Sexual Abuse Help (Mt. Eden, Auckland, New Zealand)
References in periodicals archive ?
These effects are especially felt for those affected by aneurysmal subarachnoid hemorrhage (aSAH).
Naraoka, "Effect of a free radical scavenger, edaravone, in the treatment of patients with aneurysmal subarachnoid hemorrhage," Neurosurgery, vol.
The role of transcranial Doppler ultrasonography in the diagnosis and management of vasospasm after aneurysmal subarachnoid hemorrhage.
Plasma taurine as a predictor of poor outcome in patients with mild neuro logical deficits after aneurysmal subarachnoid hemorrhage.
A snapshot of the global therapeutic scenario for Aneurysmal Subarachnoid Hemorrhage (SAH).
High-dose intraarterial verapamil in the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
Cardiac troponin I predicts myocardial dysfunction in aneurysmal subarachnoid hemorrhage.
Although there has been considerable amount of research on aneurysmal subarachnoid hemorrhage (aSAH) patients; the effect of the basic cerebrospinal fluid (CSF) analysis, which are routinely performed in such patients at even the most remote centers, is seldom studied.
We have good data on aneurysmal subarachnoid hemorrhage from all over the world," Dr.
27 September 2010 - Swiss biopharmaceutical company Actelion Ltd (VTX: ATLN) said today that clazosentan aimed to reduce vasospasm-related morbidity and all-cause mortality in clipped patients following aneurysmal subarachnoid hemorrhage (aSAH) failed to meet primary endpoint in CONSCIOUS-2 study.